Page last updated: 2024-08-16
sb 202190 and morphine
sb 202190 has been researched along with morphine in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Batistela, AP; Carvalho, TT; Cunha, FQ; Cunha, TM; Ferreira, SH; Flauzino, T; Otaguiri, ES; Verri, WA; Zarpelon, AC | 1 |
Other Studies
1 other study(ies) available for sb 202190 and morphine
| Article | Year |
|---|---|
Granulocyte-colony stimulating factor (G-CSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice.
Topics: Androstadienes; Animals; Dose-Response Relationship, Drug; Enzyme Activation; Flavonoids; Granulocyte Colony-Stimulating Factor; Humans; Hyperalgesia; Imidazoles; Injections, Spinal; Injections, Subcutaneous; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Morphine; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Pyridines; Recombinant Proteins; Spinal Cord; Wortmannin | 2011 |